Putting resistance under the microscope

Phase 4

Completed

• Conditions: De weerstand van de patiënt t.o.v. de operatie; patients resistance; perioperative resistance

• Registration Number: NL-OMON34255
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 400

Inclusion Criteria

age >= 18 years, day-case surgery patients

Exclusion Criteria

Patients with the following features: mental retardation, language barrier.
Patients who undergo the following interventions: surgery of the eye, MDL surgery, ESWL treatment, chronic pain relief treatment.
Patients who take psychofarmaca.
Contra-indications for lorazepam use, like Myasthenia Gravis and liver disease, will be excluded too.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Quality of recovery, aggression, anxiety, fatigue, depression symptoms. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>pharmacogenetic background lorazepam</p><br>